Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Replicon NeuroTherapeutics awarded grant for replicon development

Jan. 31, 2003

Apoptosis-inducing glucose derivatives prepared and tested by Nisshin Seifun and Kyorin team

Jan. 31, 2003

Schering presents new inhibitors of CDK and/or GSK-3

Jan. 31, 2003

Tarceva phase III trial in pancreatic cancer achieves target enrollment

Jan. 30, 2003

Triapine enters further phase II trial in prostate cancer

Jan. 29, 2003

Onyx discontinues development of ONYX-015 to focus on Bay-43-9006

Jan. 29, 2003

New data on once-daily lonafarnib in patients with advanced solid tumors

Jan. 28, 2003

Lilly claims antitumor benzoylsulfonamides and sulfonylbenzamidines

Jan. 28, 2003

rHu-KGF reduces severe oral mucositis in bone marrow transplant patients

Jan. 27, 2003

Antiinflammatory effects of omega-3 fatty acids

Jan. 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...